t145

T145 inhibits growth of Enterococcus faecalis, Staphylococcus aureus and Mycobacterium tuberculosis (Mtb) with sub μg/ml potencies that are potentially therapeutically valuable. T145 minimizes selection of spontaneous resistant mutants, a trait that prolo

BMT-145027 是一种 mGluR5 的正变构调节剂，没有内在的激动剂活性 (EC50 = 47 nM)。

AT-1459 is a novel direct thrombin inhibitor with antithrombotic efficacy.

Antibacterialagent 145 (compound 1b)为依赖于细菌铁摄取途径的抗菌剂，能破坏细胞质膜完整性并抑制细菌细胞代谢，同时对正常细胞具有低细胞毒性。

Antitumor agent-145（Compound Ir5）是一种肿瘤抑制剂，具有显著的荧光特性和线粒体靶向性，激发波长为405 nm，通过诱导necroptosis及激活程序性坏死关联的免疫反应发挥抗癌作用。